Young adults carrying ApoE4, a genetic risk factor for late-onset AD, are found to have increased levels of MCT2 and decreased levels of MCT4 in the posterior cingulate of the limbic system [96,97]. This evidence concerns the gene SLC16A7 and Alzheimer disease.